Membrane toxicity accounts for apoptosis induced by realgar nanoparticles in promyelocytic leukemia HL-60 cells

Biological Trace Element Research

Volumn 103, Issue 2, 2005, Pages 117-132

  Ye, Han Qing ^a   Gan, Lu ^a   Yang, Xiang Liang ^a   Xu, Hui Bi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; Arsenic; Lactate dehydrogenase release; Lipid peroxidation; Membrane fluidity; Nanoparticles; Realgar

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; DNA; LACTATE DEHYDROGENASE; NANOPARTICLE; REALGAR; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CELL MEMBRANE PERMEABILITY; CELL STRAIN HL 60; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LIPID MEMBRANE; PROMYELOCYTIC LEUKEMIA;

APOPTOSIS; ARSENICALS; CELL CYCLE; CELL MEMBRANE; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DNA FRAGMENTATION; HL-60 CELLS; HUMANS; MALONDIALDEHYDE; MITOCHONDRIA; NANOSTRUCTURES; PARTICLE SIZE; SULFIDES;

EID: 18244384451     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:103:2:117     Document Type: Article

References (35)

1. X. Cai, Y. Yu, Y. Huang, et al., Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells, Leukemia 17(7), 1333-1337 (2003).
2. M. Lu, J. Levin, E. Sulpice, et al., Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines, Exp. Hematol. 27(5), 845-852 (1999).
3. D. P. Lu, J. Y. Qiu, B. Jiang, et al., Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report, Blood, 99(9), 3136-3143 (2002).
4. H. Y. Hao, Z. P. Teng, and D. P. Lu, Study on the role of PML-RARalpha and RARalpha fusion proteins in NB4 cell apoptosis induced by arsenic trisulfide, Zhongguo Shi Yan Xue Ye Xue Za Zhi 10(2), 108-111 (2002) (in Chinese).
5. Y. H. Du and P. C. Ho, Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines, Cancer Chemother. Pharmacol. 47(6), 481-490 (2001).
6. W. H. Park, Y. H. Choi, C. W. Jung, et al., Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis, Biochem. Biophys. Res. Commun. 300(1), 230-235 (2003).
7. P. Y. Siu Katy, Y. W. Chan Judy, and K. P. Fung, Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: Inhibition of proliferation and induction of apoptosis, Life Sci. 71(3), 275-285 (2002).
8. K. Salnikow and M. D. Cohen. Backing into cancer: effects of arsenic on cell differentiation, Toxicol. Sci. 65(2), 161-163 (2002).
9. D. P. Lu and Q. Wang, Current study of APL treatment in China, Int. J. Hematol. 76 (Suppl. 1), 316-318 (2002).
10. F. R. Wang, Pharmacokinetic study of oral tetra-arsenic tetra-sulfide complex and with excipient, PhD thesis, Peking University, Beijing (2001).
11. V. Labhasetwar, Nanoparticles for drug delivery, Pharm. News, 4, 28-31 (1997).
12. S. Shinji, S. Norio, K. Hiroshi, et al., Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches, Int. J. Pharm. 149(1), 93-106 (1997).
13. D. F. Nixon, C. Hioe, and P. D. Chen. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity, Vaccine 14, 1523-1530 (1996).
14. J. Molpeceres, M. Guzman, and M. R. Aberturas, Application of central composite designs to the preparation of polycaprolactone nanoparticles by solvent displacement, J. Pharm. Sci. 85, 206-213 (1996).
15. S. Mitra, U. Gaur, P. C. Ghosh, et al., Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier, J. Control. Release 74(1-3), 317-323 (2001).
16. S. Y. Kim, J. C. Ha, and Y. M. Lee. Poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide)/poly(epsilon-caprolactone) (PCL) amphiphilic block copolymeric nanospheres. II. Thermoresponsive drug release behaviors, J. Control. Release 65, 345-358 (2000).
17. Y. Zhang, N. Kohler, and M. Zhang, Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake, Biomaterials 23(7), 1553-1561 (2002).
18. M. P. Desai, V. Labhasetwar, and E. Walter, The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent, Pharm. Res. 14, 1568-1573 (1997).
19. Y. Deng, H. B. Xu, K. X. Huang, et al., Size effects of realgar particles on apoptosis in human umbilical vein endothelia cell line: ECV304, Pharm. Res. 44, 513-518 (2001).
20. H. Tada, O. Shiho, K. Kuroshima, et al., An improved colorimetric assay for interleukin 2, J. Immunol. Methods 93(2), 157-165 (1986).
21. X. S. Liu, C. B. Kim, J. Yang, et al., Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c, Cell, 86 147-157 (1996).
22. W. H. Matsui, D. E. Gladstone, M. S. Vala, et al., The role of growth factors in the activity of pharmacological differentiation agents, Cell Growth Differ. 13, 275-283 (2002).
23. C. F. Yang, H. M. Shen, Y. Shen, et al., Cadmium-induced oxidative cellular damage in human fetal lung fibroblasts(MRC-5 cells)., Environ. Health Perspect. 105, 712-716 (1997).
24. I. Nathan, I. Ben-Valid, R. Henzel, et al., Alterations in membrane lipid dynamics of leukemic cells undergoing growth arrest and differentiation: dependency on the inducing agent, Exp. Cell Res. 239, 442-446 (1998).
25. A. A. Welder, R. Grant, J. Bradlaw, et al., A primary culture system of adult rat heart cells for the study of toxicologic agents, In Vitro Cell Dev. Biol. 27A(12), 921-926 (1991).
26. S. Sen and D. Incalei, Apoptosis: biochemical events and relevance to cancer chemotherapy, FEBS Lett. 307, 122-127 (1992).
27. R. J. Bold, P. M. Termuhlen, and D. J. McConkey, Apoptosis, cancer and cancer therapy, Surg. Oncol. 6(3), 133-142 (1997).
28. N. Larochette, D. Decaudin, E. Jacotot, et al., Arsenite induces apoptosis via a direct effect on the mitochondrial permeability transition pore, Exp. Cell Res. 249, 413-421 (1999).
29. Y. Nakagawa, Y. Akao, H. Morikawa, et al., Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines, Life Sci. 70, 2253-2269 (2002).
30. T. Slater, B. Sawyer, and U. Strauli. Studies on succinate-tetrazolium reductase system. III. Points of coupling of four different tetrazolium salts, Biochim. Biophys Acta 77, 383-393 (1963).
31. M. Rizzardini, M. Lupi, S. Bernasconi, et al., Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid, J. Neurol. Sci. 207, 51-58 (2003).
32. T. Bohler, J. Waiser, H. Hepburn, et al., TNF-alpha and IL-1alpha induce apoptosis in subconfluent rat mesangial cells. Evidence for the involvement of hydrogen peroxide and lipid peroxidation as second messengers, Cytokine 12(7), 986-991 (2000).
33. X. Y. Yu, N. Takahashi, T. L. Croxton, et al., Modulation of bronchial epithelial cell barrier function by in vitro ozone exposure, Environ. Health Perspect. 102(12), 1068-1072 (1994).
34. L. Schiaffonati and L. Tiberio, Gene expression in liver after toxic injury: analysis of heat shock response and oxidative stress-inducible genes, Liver, 17(4), 183-191 (1997).
35. O. Tomáš, A. Evzen, O. Veronika, et al., Effect of aminophospholipid glycation on order parameter and hydration of phospholipid bilayer, Biophys. Chem. 80(3), 165-177 (1999).